Jane Street Group, LLC Geron Corp Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $82,149 - $98,303	19,700 New	19,700 $89,000
Q2 2021 Aug 16, 2021	BUY	$1.25 - $1.83 $32,000 - $46,848	25,600 Added 83.39%	56,300 $79,000
Q3 2018 Nov 14, 2018	SELL	$1.76 - $6.38 $54,736 - $198,418	-31,100 Reduced 50.32%	30,700 $54,000
Q2 2018 Aug 15, 2018	SELL	$3.29 - $4.82 $91,462 - $133,996	-27,800 Reduced 31.03%	61,800 $212,000
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $162,176 - $535,808	89,600 New	89,600 $381,000

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.28B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.